Rapacuronium bromide

Drug Profile

Rapacuronium bromide

Alternative Names: ORG 9487; Raplon

Latest Information Update: 18 Apr 2001

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Organon Teknika
  • Class Androstanols; Muscle relaxants
  • Mechanism of Action Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Muscle hypertonia

Most Recent Events

  • 18 Apr 2001 Discontinued-preregistration for Hypertonia in Europe (IV)
  • 05 Apr 2001 Withdrawn for Hypertonia in USA (IV)
  • 16 Feb 2001 A study in paediatric patients has been added to the Muscular Disorders therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top